Navigation Links
Ohr Pharmaceutical Announces $5 Million Financing from Exercise of Warrants
Date:4/22/2013

NEW YORK, April 22, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs, today announced that Ohr raised approximately $5.05 million dollars from institutional and accredited shareholders through the exercise of Series B Warrants.  The Company intends to use the net proceeds from this offering to complete its Phase II Squalamine eye drop clinical trial for the wet form of age-related macular degeneration, further the clinical development of Squalamine eye drops for the treatment of other neovascular ophthalmic disorders, fund continued development of other pipeline molecules, and for general corporate purposes.

"The Company's ability to raise significant capital on favorable terms and provide itself with a cash runway into 2015 is a confirmation of the continued progress on the Company's clinical development programs," said Ira Greenstein , Chairman of the Board of Directors. "The additional capital will allow us to continue to execute on the Company's strategy and increases shareholder equity, one of the requirements for our proposed uplisting to Nasdaq."

"We would like to thank our shareholders for their continued support," said Dr. Irach B. Taraporewala, CEO of Ohr Pharmaceutical. "I am pleased to report that we anticipate completing 50% enrollment in the Phase II Squalamine eye drop trial midyear and look forward to continuing to update shareholders on the progress of our clinical trial and business initiatives."   

About the Warrant Exercise

On April 5, 2013, the Company gave notice to Series B Warrant holders that the Company was opting to accelerate the expiration date of the Series B Warrants to April 18, 2013. Additionally, as an incentive to encourage exercise of the Series B Warrants, the Company offered to those Series B Warrant holders
'/>"/>

SOURCE Ohr Pharmaceutical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia
2. Shimadzu's New DSC-60 Plus Series Differential Scanning Calorimeters Offer High-Sensitivity Analysis in Polymer, Food and Pharmaceutical Applications
3. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
4. PharmaDirections Celebrates 10 Years of Success for Their Virtual Biotech and Pharmaceutical Clients
5. North American Nuclear Medicine / Radiopharmaceutical Market Worth $5.55 Billion by 2017
6. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
7. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
8. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
9. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
10. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 OHAUS ... portable, and mechanical balances and scales, proudly announces ... has won Laboratory Equipment magazine’s 2014 “Readers' Choice” ... second consecutive year the Explorer was voted the ... annual Readers’ Choice Awards celebrates “excellence in product ...
(Date:7/22/2014)... og SHENZHEN , Kina, 22. ... LTD, (BGI Tech), et datterselskab af BGI, verdens ... ny human whole exome-sekvenseringstjeneste baseret på Complete Genomics ... anset i branchen for at levere patenterede sekvenseringsteknologier ... alle typer varianter, blev købt af BGI i ...
(Date:7/22/2014)... SHENZHEN, China , 22 juli 2014 /PRNewswire/ ... dochtermaatschappij van BGI, ,s wereld grootste organisatie op het ... een nieuwe service ten behoeve van hele menselijke genoomsequentie ... Complete Genomics. In 2013 acquireerde BGI ... hoog aanzien staat vanwege de in eigen beheer ontwikkelde ...
(Date:7/22/2014)... Hussey Copper , a leader in copper manufacturing ... Pullman Regional Hospital,s conversion of more than 1,100 touch ... at a nominal cost.  This reasonably priced surface kills ... within 2 hours of exposure 1 and will aid ... in its facilities. Pullman Regional Hospital, in ...
Breaking Biology Technology:OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech lancerer Human Whole Exome-sekvenseringstjeneste på Complete Genomics avancerede platform 2BGI Tech introduceert service op gebied van hele menselijke exoomsequencing op geavanceerd Complete Genomics-platform 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3
... Therapeutics, Inc.,a privately-held company focused on improving the ... today that the company,has raised $15.5 million in ... was co-led by New Leaf Ventures and Clarus ... conjunction with the financing,Kathleen LaPorte, managing director, New ...
... ATLANTA and ST. LOUIS, Sept. 6 ... organization (GPO) serving St. Louis-,based Sisters of ... with Elekta,enabling members to begin purchasing Elekta,s ... ) Under the agreement, Mercy ...
... Primary Endpoint Could be Acceptable With Fewer ... Patients Than Originally Planned, ... CTIC ) (MTAX: CTIC) announced today that following,discussions with the ... for patients with aggressive non-Hodgkin,s lymphoma,(NHL) the Company has decided ...
Cached Biology Technology:Pearl Therapeutics Raises $15.5 Million in Private Financing 2Pearl Therapeutics Raises $15.5 Million in Private Financing 3Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions 2Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission 2Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission 3Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission 4
(Date:7/22/2014)... prevent their daughters from breeding, and kill their grandchildren ... desert creatures which live in groups with a dominant ... alpha female can flourish when it maintains the sole right ... life, also found in many animals such as ants and ... Dominant meerkats control breeding within their group through violence, by ...
(Date:7/21/2014)... part of a multinational, collaborative effort, researchers from Canada,s ... identify over 100 locations in the human genome associated ... the largest genomic study published on any psychiatric disorder ... , point to biological mechanisms and pathways that may ... treating the disorder, which has seen little innovation in ...
(Date:7/21/2014)... there are reasons mammoths and mastodons could have been ... research from the University of Cincinnati, the famously fuzzy ... before it was trendy at the end of ... Crowley, an assistant professor of geology and anthropology, shows ... likely were year-round residents and not nomadic migrants as ...
Breaking Biology News(10 mins):International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3Mammoth and mastodon behavior was less roam, more stay at home 2Mammoth and mastodon behavior was less roam, more stay at home 3
... fumes, risk developing increased clumsiness and the result may ... of a study at the University of Gothenburg, Sweden, of ... in Sweden work full-time with welding, while many more carry ... has shown that the concentration of manganese in the air ...
... Murphy works with some of the most powerful tools in ... These constructions sound a bit like socket wrenches, which can ... or to loosen a rusted-tight one-inch bolt using a very ... associate professor of biomedical engineering and orthopedics and rehabilitation at ...
... of threatened loggerhead sea turtles has revealed two previously unknown ... important habitat for at least three separate populations of the ... Biological Conservation . The two sites, located ... and the northern tip of the Yucatan Peninsula, were found ...
Cached Biology News:Increased clumsiness in former welders 2Smallest tools could give biggest results in bone repair 2Smallest tools could give biggest results in bone repair 3Satellite tracking reveals sea turtle feeding hotspots 2Satellite tracking reveals sea turtle feeding hotspots 3